We are pleased to announce our newly published paper that offers practical guidance from international trial networks and site experience, providing a roadmap to help inexperienced sites qualify for upcoming clinical trials.
Since, numerous potential treatments are being developed for FSHD, clinical trial readiness is key. Project Mercury and global collaborations are working to overcome barriers to delivering effective FSHD therapies as numerous potential treatments are developed.
Thank you to Lawrence Korngut, Joost Kools, Nicol Voermans and all co-authors.
Read full paper here: Toolkit-for-new-facioscapulohumeral-muscular-dystrophy-trial-sites